These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28981352)

  • 1. Imaging Genetic Heterogeneity in Glioblastoma and Other Glial Tumors: Review of Current Methods and Future Directions.
    Chow D; Chang P; Weinberg BD; Bota DA; Grinband J; Filippi CG
    AJR Am J Roentgenol; 2018 Jan; 210(1):30-38. PubMed ID: 28981352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics for precision medicine in glioblastoma.
    Aftab K; Aamir FB; Mallick S; Mubarak F; Pope WB; Mikkelsen T; Rock JP; Enam SA
    J Neurooncol; 2022 Jan; 156(2):217-231. PubMed ID: 35020109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.
    Fathi Kazerooni A; Bakas S; Saligheh Rad H; Davatzikos C
    J Magn Reson Imaging; 2020 Jul; 52(1):54-69. PubMed ID: 31456318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
    Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD
    J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine.
    Sanchez I; Rahman R
    Curr Oncol Rep; 2024 Oct; 26(10):1213-1222. PubMed ID: 39009914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response.
    Verduin M; Compter I; Steijvers D; Postma AA; Eekers DBP; Anten MM; Ackermans L; Ter Laan M; Leijenaar RTH; van de Weijer T; Tjan-Heijnen VCG; Hoeben A; Vooijs M
    Dis Markers; 2018; 2018():2908609. PubMed ID: 29581794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic investigation of multicentric glioblastoma multiforme: case report.
    Schroeder B; Shah N; Rostad S; McCullough B; Aguedan B; Foltz G; Cobbs C
    J Neurosurg; 2016 May; 124(5):1353-8. PubMed ID: 26473785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging and genetic influence in treating brain neoplasms.
    Hygino da Cruz LC; Kimura M
    Neuroimaging Clin N Am; 2015 Feb; 25(1):121-40. PubMed ID: 25476517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light.
    Maggio I; Franceschi E; Gatto L; Tosoni A; Di Nunno V; Tonon C; Brandes AA
    Expert Rev Anticancer Ther; 2021 Nov; 21(11):1265-1272. PubMed ID: 34433354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial comment: Radiogenomics of glioblastoma: shifting the focus from tumor cells to immune microenvironment.
    Politi LS; Levi R
    Eur Radiol; 2023 Jan; 33(1):207-208. PubMed ID: 36305901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].
    Goryaynov SA; Gol'dberg MF; Golanov AV; Zolotova SV; Shishkina LV; Ryzhova MV; Pitskhelauri DI; Zhukov VY; Usachev DY; Belyaev AY; Kondrashov AV; Shurkhay VA; Potapov AA
    Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(3):5-16. PubMed ID: 28665384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Glioblastoma: Molecular and Clinical Factors That Affect Outcome After Malignant Progression of a Lower Grade Tumor.
    Gessler F; Zappi J; Konczalla J; Bernstock JD; Forster MT; Wagner M; Mittelbronn M; Seifert V; Senft C
    World Neurosurg; 2017 Jun; 102():49-55. PubMed ID: 28263929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Histologic Low-Grade Glioma with 7 Gain, 10 Loss-A Wolf in Sheep's Clothing.
    Pollom EL; Soltys SG
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1137-1138. PubMed ID: 33714521
    [No Abstract]   [Full Text] [Related]  

  • 15. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.
    Shiroishi MS; Boxerman JL; Pope WB
    Neuro Oncol; 2016 Apr; 18(4):467-78. PubMed ID: 26364321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    Wang L; Wang H; D'Angelo F; Curtin L; Sereduk CP; Leon G; Singleton KW; Urcuyo J; Hawkins-Daarud A; Jackson PR; Krishna C; Zimmerman RS; Patra DP; Bendok BR; Smith KA; Nakaji P; Donev K; Baxter LC; Mrugała MM; Ceccarelli M; Iavarone A; Swanson KR; Tran NL; Hu LS; Li J
    PLoS One; 2024; 19(4):e0299267. PubMed ID: 38568950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive survey on the use of deep learning techniques in glioblastoma.
    El Hachimy I; Kabelma D; Echcharef C; Hassani M; Benamar N; Hajji N
    Artif Intell Med; 2024 Aug; 154():102902. PubMed ID: 38852314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Glioblastoma.
    Nam JY; de Groot JF
    J Oncol Pract; 2017 Oct; 13(10):629-638. PubMed ID: 29020535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
    Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
    Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI texture features as biomarkers to predict MGMT methylation status in glioblastomas.
    Korfiatis P; Kline TL; Coufalova L; Lachance DH; Parney IF; Carter RE; Buckner JC; Erickson BJ
    Med Phys; 2016 Jun; 43(6):2835-2844. PubMed ID: 27277032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.